{"id":1012805,"date":"2026-10-22T16:06:19","date_gmt":"2026-10-22T20:06:19","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-host-investor-day-on-december-8-2026\/"},"modified":"2026-10-22T16:06:19","modified_gmt":"2026-10-22T20:06:19","slug":"ligand-to-host-investor-day-on-december-8-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-host-investor-day-on-december-8-2026\/","title":{"rendered":"Ligand to Host Investor Day on December 8, 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">JUPITER, Fla., Oct.  22, 2026  (GLOBE NEWSWIRE) &#8212; Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its annual Investor Day will take place on Tuesday, December 8, 2026 from 10:30 a.m. to 12:00 p.m. ET at the Harvard Club of New York City at 35 West 44th Street, New York, NY 10036.<\/p>\n<p align=\"justify\">The event will include presentations from Ligand CEO Todd Davis, CFO Tavo Espinoza and other members of the Ligand senior management team. Presentations will highlight the company\u2019s strategy, investment activity, royalty portfolio, and long-term financial outlook. Wes Kaupinen, Founder and CEO of Palvella Therapeutics, a Ligand partner, will be a guest speaker at the event and discuss the progress of QTORIN\u2122 3.9% rapamycin anhydrous gel (QTORIN\u2122 rapamycin), which is in development for the treatment of microcystic lymphatic malformations, cutaneous venous malformations, clinically significant angiokeratomas, and additional rare disease indications.<\/p>\n<p align=\"justify\">A live webcast of the event will be accessible through Ligand\u2019s Investor Relations <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1_effSH-WEizV4NCvV0QG3W4iMjOyu1jZC5Op6PH9ofrsI6efnGqr3n8GNhjRUCxEankuMCBLiKni3-Ag4HeYQBJq9nW6hFyVeStRhIYQhzZ1M1CHWkTWyAA90QGA4JtbsQ-xUE1hB73E5gEVxGJvXU_xTyQ_OzyXRg_VRhA6r4=\" rel=\"nofollow\" target=\"_blank\">Events Page<\/a>. A webcast replay will be available following the conclusion of the event.<\/p>\n<p align=\"justify\">Investors and analysts can register for the event <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dTp_MU5VEmXaIg1gK6At-eftXgMQp0b1QPXbWo3B-5e2dHLefLIrYEv-j1NlrZIE4ocmuMIIP70YaalN-xl3OxUgqDr9Yac3yND-T1KcqzgHGYFhVKQgSfroREtNTiHAAOd67Nj2s0zdAUKl0g5Pzxz-CdA7KzrLn0iU0fUpQLFjvtVjUIzkUMfAO5jhtSsOP9DfBK8RA4g8cM-mqMwvBA==\" rel=\"nofollow\" target=\"_blank\">here<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>About Ligand<\/strong><br \/>\n        <br \/>Ligand is a leading royalty aggregator, partnering with biopharmaceutical companies to finance and advance late-stage clinical development programs. Ligand owns and manages one of the largest and most diversified portfolios of biopharmaceutical royalties in the industry, with economic interests in more than 200 development and commercial-stage assets. Ligand funds high-value programs in exchange for long-term economic interests, aligning capital with clinical and commercial success. Ligand\u2019s royalty portfolio is designed to deliver consistent and predictable revenue streams across a broad range of therapeutic assets. Ligand also licenses its proprietary technologies, Captisol\u00ae and NITRICIL\u2122, to support drug development and formulation across its global partner network. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=IO17YAdL4Te7C-4_xcOloeZUUCW9s8BH9LFVy1XsNiHZZzNECEXWG4UXFqtcqT8ZBJEil6KEQrReVFB_Gg70wQ==\" rel=\"nofollow\" target=\"_blank\">www.ligand.com<\/a> or follow Ligand on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VgXftwAi3h4bF6o6WqtHZpXoCyT0Kpe1vpZmH8cgNflCyU0bgYF5Ue4Y4cop4mYeYCSKGigBvzSdeF2YWgXo9g==\" rel=\"nofollow\" target=\"_blank\">X<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uRObIhEfgDpS1IzVlapNhovWan-4hpb2lRYcI4d_Uqs2USdgf9dVzfpTIzD28DYWZC3OpP2BLh3zmW6g67IYQuuljP8kZLrYkbKyUvb4ywze-QWLKns7ahFU9MzgVHhd\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p align=\"justify\">Contacts<\/p>\n<p align=\"justify\">Investors:<br \/>Melanie Herman <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GXO7UwYHcFLTrC5W8V6_CM550L8E6TSxBZZFWbFbK2m5aZdKIczOR3mXjP0hs8YRrRpv9UBfbGekvgGejqF4nkNook60i7kW9R5RqGOi4oM=\" rel=\"nofollow\" target=\"_blank\"><u>investors@ligand.com<\/u><\/a><br \/>(858) 550-7761<\/p>\n<p align=\"justify\">Media: <br \/>Kellie Walsh <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=B6p1gQMySlQi9sKWSgYjCqKA0unI6uk2Rd0zlmPruGyF24FspwC0RO4o9tHO9HQw0Nb1bTZr_sVVNKPUAvZiyDS4ijqR-mH26yIhz2U7FFA=\" rel=\"nofollow\" target=\"_blank\"><u>media@ligand.com<\/u><\/a><br \/>(914) 315-6072<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MTM5MCM3OTEwOTE0IzIwMDY1NjQ=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/N2ZkM2Y2YzEtYmIxYi00ZjkwLThiZDItNmRkYjA3MDg5N2JiLTEwMTgxMzctMjAyNi0xMC0yMi1lbg==\/tiny\/Ligand-Pharmaceuticals.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>JUPITER, Fla., Oct. 22, 2026 (GLOBE NEWSWIRE) &#8212; Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its annual Investor Day will take place on Tuesday, December 8, 2026 from 10:30 a.m. to 12:00 p.m. ET at the Harvard Club of New York City at 35 West 44th Street, New York, NY 10036. The event will include presentations from Ligand CEO Todd Davis, CFO Tavo Espinoza and other members of the Ligand senior management team. Presentations will highlight the company\u2019s strategy, investment activity, royalty portfolio, and long-term financial outlook. Wes Kaupinen, Founder and CEO of Palvella Therapeutics, a Ligand partner, will be a guest speaker at the event and discuss the progress of QTORIN\u2122 3.9% rapamycin anhydrous gel (QTORIN\u2122 rapamycin), which &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-host-investor-day-on-december-8-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Ligand to Host Investor Day on December 8, 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1012805","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ligand to Host Investor Day on December 8, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-host-investor-day-on-december-8-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ligand to Host Investor Day on December 8, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"JUPITER, Fla., Oct. 22, 2026 (GLOBE NEWSWIRE) &#8212; Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its annual Investor Day will take place on Tuesday, December 8, 2026 from 10:30 a.m. to 12:00 p.m. ET at the Harvard Club of New York City at 35 West 44th Street, New York, NY 10036. The event will include presentations from Ligand CEO Todd Davis, CFO Tavo Espinoza and other members of the Ligand senior management team. Presentations will highlight the company\u2019s strategy, investment activity, royalty portfolio, and long-term financial outlook. Wes Kaupinen, Founder and CEO of Palvella Therapeutics, a Ligand partner, will be a guest speaker at the event and discuss the progress of QTORIN\u2122 3.9% rapamycin anhydrous gel (QTORIN\u2122 rapamycin), which &hellip; Continue reading &quot;Ligand to Host Investor Day on December 8, 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-host-investor-day-on-december-8-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-22T20:06:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MTM5MCM3OTEwOTE0IzIwMDY1NjQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-to-host-investor-day-on-december-8-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-to-host-investor-day-on-december-8-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Ligand to Host Investor Day on December 8, 2026\",\"datePublished\":\"2026-10-22T20:06:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-to-host-investor-day-on-december-8-2026\\\/\"},\"wordCount\":313,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-to-host-investor-day-on-december-8-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1MTM5MCM3OTEwOTE0IzIwMDY1NjQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-to-host-investor-day-on-december-8-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-to-host-investor-day-on-december-8-2026\\\/\",\"name\":\"Ligand to Host Investor Day on December 8, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-to-host-investor-day-on-december-8-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-to-host-investor-day-on-december-8-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1MTM5MCM3OTEwOTE0IzIwMDY1NjQ=\",\"datePublished\":\"2026-10-22T20:06:19+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-to-host-investor-day-on-december-8-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-to-host-investor-day-on-december-8-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-to-host-investor-day-on-december-8-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1MTM5MCM3OTEwOTE0IzIwMDY1NjQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1MTM5MCM3OTEwOTE0IzIwMDY1NjQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-to-host-investor-day-on-december-8-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ligand to Host Investor Day on December 8, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ligand to Host Investor Day on December 8, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-host-investor-day-on-december-8-2026\/","og_locale":"en_US","og_type":"article","og_title":"Ligand to Host Investor Day on December 8, 2026 - Market Newsdesk","og_description":"JUPITER, Fla., Oct. 22, 2026 (GLOBE NEWSWIRE) &#8212; Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its annual Investor Day will take place on Tuesday, December 8, 2026 from 10:30 a.m. to 12:00 p.m. ET at the Harvard Club of New York City at 35 West 44th Street, New York, NY 10036. The event will include presentations from Ligand CEO Todd Davis, CFO Tavo Espinoza and other members of the Ligand senior management team. Presentations will highlight the company\u2019s strategy, investment activity, royalty portfolio, and long-term financial outlook. Wes Kaupinen, Founder and CEO of Palvella Therapeutics, a Ligand partner, will be a guest speaker at the event and discuss the progress of QTORIN\u2122 3.9% rapamycin anhydrous gel (QTORIN\u2122 rapamycin), which &hellip; Continue reading \"Ligand to Host Investor Day on December 8, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-host-investor-day-on-december-8-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-10-22T20:06:19+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MTM5MCM3OTEwOTE0IzIwMDY1NjQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-host-investor-day-on-december-8-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-host-investor-day-on-december-8-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Ligand to Host Investor Day on December 8, 2026","datePublished":"2026-10-22T20:06:19+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-host-investor-day-on-december-8-2026\/"},"wordCount":313,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-host-investor-day-on-december-8-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MTM5MCM3OTEwOTE0IzIwMDY1NjQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-host-investor-day-on-december-8-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-host-investor-day-on-december-8-2026\/","name":"Ligand to Host Investor Day on December 8, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-host-investor-day-on-december-8-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-host-investor-day-on-december-8-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MTM5MCM3OTEwOTE0IzIwMDY1NjQ=","datePublished":"2026-10-22T20:06:19+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-host-investor-day-on-december-8-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-host-investor-day-on-december-8-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-host-investor-day-on-december-8-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MTM5MCM3OTEwOTE0IzIwMDY1NjQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MTM5MCM3OTEwOTE0IzIwMDY1NjQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-host-investor-day-on-december-8-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Ligand to Host Investor Day on December 8, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1012805","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1012805"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1012805\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1012805"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1012805"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1012805"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}